US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Onward Med NV

5.22

+0.11502.25%

Volume:200.00

Turnover:1.04K

Market Cap:233.04M

PE:-5.12

High:5.22

Open:5.22

Low:5.22

Close:5.10

52wk High:7.13

52wk Low:4.44

Shares:44.69M

Float Shares:- -

Volume Ratio:0.26

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0188

ROE:-167.80%

ROA:-43.66%

PB:7.08

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors

Press Release: ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025

Press Release: ONWARD Medical Announces Results of its Annual General Meeting of Shareholders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ONWRY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONWRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONWRY\",,,,,undefined,":{"symbol":"ONWRY","market":"US","secType":"STK","nameCN":"Onward Med NV","latestPrice":5.215,"timestamp":1771008890058,"preClose":5.1,"halted":0,"volume":200,"delay":15,"changeRate":0.022549019607843182,"floatShares":0,"shares":44685656,"eps":-1.0188,"marketStatus":"Trading","change":0.115,"latestTime":"02-13 13:54:50 EST Delay","open":5.215,"high":5.215,"low":5.215,"amount":1043,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.0188,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"exchange":"OTCQX","adjPreClose":5.1,"volumeRatio":0.255973},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONWRY\",,,,,undefined,":{"symbol":"ONWRY","floatShares":0,"roa":"-43.66%","roe":"-167.80%","lyrEps":0,"volumeRatio":0.255973,"shares":44685656,"dividePrice":0,"high":5.215,"amplitude":0,"preClose":5.1,"low":5.215,"week52Low":4.44,"pbRate":"7.08","psRate":"72.30","week52High":7.13,"institutionHeld":0,"latestPrice":5.215,"eps":-1.0188,"divideRate":0,"volume":200,"delay":15,"ttmEps":-1.0188,"open":5.215,"prevYearClose":5.38,"prevWeekClose":5.106,"prevMonthClose":5.5,"prevQuarterClose":5.38,"fiveDayClose":5.106,"twentyDayClose":5.58,"sixtyDayClose":5.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONWRY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONWRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONWRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1769144400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONWRY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549302805","title":"Press Release: ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2549302805","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549302805?lang=en_us&edition=fundamental","pubTime":"2025-07-07 13:30","pubTimestamp":1751866200,"startTime":"0","endTime":"0","summary":"THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 OF THE EUROPEAN MARKET ABUSE REGULATION . -- Denison is Professor of Clinical Neurosciences at the University of. Oxford and was previously Vice President of Research and Core. Technologies at Medtronic. He is a co-founder and Chief Engineer of. Science Advisor. He will depart the Board of Directors to address new. responsibilities as Director of the Neuro-X Institute and expanded. Catalyzed by his recent appointment as Director of the Neuro-X Institute and in light of his continually expanding responsibilities as Director of NeuroRestore and Professor at EPFL , Professor Gregoire Courtine will depart the company's Board of Directors. He will continue to serve ONWARD as Co-Founder and Science Advisor, as part of the Company's ongoing engagement with the world's foremost neuroscience innovators.The Neuro-X Institute is a multidisciplinary Swiss neuroscience research","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCI","IE00B1B80R65.USD","LU1291159041.SGD","BK4548","LU0266013472.USD","LU0077335932.USD","ONWRY","BCI","LU1892829315.USD","LU1989771016.USD","BK4192","TIMB","BK4132","BK4082"],"gpt_icon":0},{"id":"2544932811","title":"Press Release: ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2544932811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544932811?lang=en_us&edition=fundamental","pubTime":"2025-06-17 13:30","pubTimestamp":1750138200,"startTime":"0","endTime":"0","summary":"EINDHOVEN, the Netherlands, June 17, 2025  -- ONWARD Medical N.V. , the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury  and other movement disabilities, today announces its Q1 2025 business update and year-to-date highlights:. -- Commercial traction: Following FDA market authorization, the Company met. its Q1 objective for the limited initial phase of its US launch of the. ARC-EX System, hiring, training and deploying a field organization,establishing a sales and service process, building a roster of reference. -- Technology advancement: The Company's investigational ARC-IM and. ARC-BCI platforms reached new milestones with the 4th and 5th. successful BCI implants to restore thought-driven movement, and the first. human implant of its investigational ARC-IM Lumbar Lead, which is. supporting the ARC-EX System, Pathfinder2 study results published in. In the first quarter, ONWARD announced the first hu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0077335932.USD","LU0266013472.USD","ARC","TILE","LU1291159041.SGD","IDE","R","LU1892829315.USD","ONWRY","LU1989771016.USD","BK4232","SCI","BK4082","BK4022","BK4143","BCI","BK4192","BK4548"],"gpt_icon":0},{"id":"2542153922","title":"Press Release: ONWARD Medical Announces Results of its Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542153922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542153922?lang=en_us&edition=fundamental","pubTime":"2025-06-12 01:00","pubTimestamp":1749661200,"startTime":"0","endTime":"0","summary":"THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7 OF THE EUROPEAN MARKET ABUSE REGULATION . EINDHOVEN, The Netherlands, June 11, 2025  -- ONWARD Medical N.V. , the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that that all proposed resolutions at its Annual General Meeting of Shareholders  were duly passed.The meeting was held this afternoon in Amsterdam, the Netherlands at 4:00PM CET. Full details of the resolutions approved during the AGM can be found on the Company's Investor Relations website.Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause ac","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4229","BK4548","ONWRY","BK4192","BK4195","LU0077335932.USD","SCI","LU0266013472.USD","LU1291159041.SGD","LU1989771016.USD","BCI","AGM","LU1892829315.USD","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}